perfluorobutane

Trade name: Sonazoid

Small moleculeexperimental

Perfluorobutane (PFB) is an inert, high-density colorless gas. It is a simple fluorocarbon with a n-butane skeleton and all the hydrogen atoms replaced with fluorine atoms. — Wikipedia

Clinical trial activity

16 trials · 15 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
10
Phase 3
5
Phase 4
1

Earliest trial started Aug 1, 2004 (NCT00156780)

Timeline

2000s

  1. Jan 1, 2004

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2006

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2016

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetOTHER

    Diagnostic

  • UnclearContrast agent

    Unclear contrast agent

Chemistry & pharmacology

Loading structure…

SMILES

FC(F)(F)C(F)(F)C(F)(F)C(F)(F)F
Mol. weight
238.02 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • ai 700
  • ai-700
  • ai-700
  • ai-700
  • ai-700
  • ai700 compound
  • decafluorobutane
  • decafluorobutane
  • decafluorobutane
  • decafluoro-butane
  • mp1950
  • mp 1950
  • mp-1950
  • perflubutane
  • perflubutane
  • perflubutane
  • perflubutane
  • perflubutane
  • perflubutane
  • perflubutane
  • perflubutane
  • perflubutane polymer microspheres
  • perfluorobutane
  • perfluorobutane
  • perfluorobutane sulfonate
  • sonazoid
  • sonazoid
  • sonazoid

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05470205Phase 3Aug 15, 2022National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Thomas Jefferson University, University of Bern, University of Pennsylvania
NCT04720456Phase 2Nov 30, 2021National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Thomas Jefferson University, University of Pennsylvania
NCT05068076N/AOct 4, 2021Institute of Liver and Biliary Sciences, India
NCT04006275Phase 3Jun 30, 2019Zhejiang University
NCT03245255Phase 2Dec 4, 2017General Electric, National Heart, Lung, and Blood Institute (NHLBI), Thomas Jefferson University
NCT02651090Phase 3May 1, 2017Northeastern Ohio Radiology Research and Education Fund
NCT03009266N/AFeb 1, 2017Oregon Health and Science University
NCT02737865N/AMay 1, 2016Sungkyunkwan University
NCT02733029Phase 2May 1, 2016General Electric, Harvard University
NCT02652923Phase 1/Phase 2 (Phase 2)Jan 1, 2016General Electric, National Cancer Institute (NCI), Siemens, Thomas Jefferson University
NCT02398266Phase 2Jan 1, 2016Oregon Health and Science University
NCT02489045Phase 4Apr 6, 2015National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Thomas Jefferson University, University of Pennsylvania
NCT03340870Phase 1Oct 20, 2014General Electric
NCT03335566Phase 3May 11, 2014General Electric
NCT00669851Phase 3Nov 1, 2006Acusphere
NCT00156780Phase 1Aug 1, 2004Acusphere
Showing 16 of 16 trials
Page 1 / 1

Organizations

Research & Development (15)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
General ElectricFor profit5232014
Thomas Jefferson UniversityAcademic/Hospital5532015
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Government3032015
University of PennsylvaniaAcademic/Hospital3032015
AcusphereFor profit2222004
Oregon Health and Science UniversityAcademic/Hospital2222016
Harvard UniversityAcademic/Hospital1112016
Institute of Liver and Biliary Sciences, IndiaAcademic/Hospital1112021
National Cancer Institute (NCI)Government1012016
National Heart, Lung, and Blood Institute (NHLBI)Government1012017
Northeastern Ohio Radiology Research and Education FundAcademic/Hospital1112017
SiemensFor profit1012016
Sungkyunkwan UniversityAcademic/Hospital1112016
University of BernAcademic/Hospital1012022
Zhejiang UniversityAcademic/Hospital1112019
15 organizations
Page 1 / 1